News for 'drug regulations'

For the first time, Centre allows a private player to process opium

For the first time, Centre allows a private player to process opium

Rediff.com14 Jul 2022

The central government has for the first time allowed a private company, Bajaj Healthcare, to process opium to extract alkaloids used to make pain-killers, cough syrups, and even cancer drugs. Two government factories in Ghazipur, Uttar Pradesh, and Neemuch, Madhya Pradesh, do the work yet, processing some 800 tonnes of opium gum annually to extract alkaloids. The government on Tuesday gave Thane-based Bajaj Healthcare an initial contract to process 500 tonnes of opium gum annually and wants production to be at 800 tonnes per annum (tpa) in the next five years, indicating the state's exit from the highly-regulated sector.

Covaxin safe for children: Bharat Biotech

Covaxin safe for children: Bharat Biotech

Rediff.com31 Dec 2021

Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

Why is this athlete is knocking on Human Rights' door?

Why is this athlete is knocking on Human Rights' door?

Rediff.com17 Nov 2020

Semenya has vowed to fight the regulations, but has already lost an appeal to the Court of Arbitration for Sport, and another subsequent plea to the Swiss Federal Tribunal (SFT) asking for the CAS ruling to be set aside.

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

Rediff.com4 Jan 2021

The Oxford vaccine, which also has a tie-up with the Serum Institute of India, was first administered to Brian Pinker, an 82-year-old Oxford-born dialysis patient. Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the National Health Service (NHS).

Loss making drugs may go off the shelf

Loss making drugs may go off the shelf

Rediff.com27 Jun 2008

Facing a steep rise in raw material and interest costs, pharmaceutical companies have sought an increase in prices of regulated medicines, saying otherwise they may be forced to curtail production of certain medicines that have become unprofitable.

Religare's banking bid under Ranbaxy cloud

Religare's banking bid under Ranbaxy cloud

Rediff.com1 Jun 2013

Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.

Ranbaxy provisions for settlement with US

Ranbaxy provisions for settlement with US

Rediff.com30 Jul 2014

The Gurgaon-headquartered drug maker, set to be acquired by another leading domestic company, Sun Pharmaceutical Industries, reported a consolidated net loss of Rs 186 crore for the quarter ended June.

Trump defends use of HCQ, says it works in early stages of COVID-19

Trump defends use of HCQ, says it works in early stages of COVID-19

Rediff.com29 Jul 2020

There is no evidence that the drug can fight the virus, and regulators warn it may cause heart problems.

Several dark patches in 2013's performing sectors

Several dark patches in 2013's performing sectors

Rediff.com31 Dec 2013

IT, pharma and FMCG stocks are the top performers in 2013.

Guns, drugs, and financial markets

Guns, drugs, and financial markets

Rediff.com14 Apr 2008

Finance enthusiasts are like gun advocates who say that 'guns don't kill people, people kill people'.

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil suspends Bharat Biotech's Covaxin clinical trials

Rediff.com24 Jul 2021

The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

Adverse effect of Covid-19 vaccine: What the law says

Adverse effect of Covid-19 vaccine: What the law says

Rediff.com15 Jan 2021

Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.

India defers FTA talks with European Union

India defers FTA talks with European Union

Rediff.com6 Aug 2015

Negotiators from were expected to meet in New Delhi on August 28.

Year after Janata curfew, Covid rears its ugly head again

Year after Janata curfew, Covid rears its ugly head again

Rediff.com22 Mar 2021

Millions of people across the country stayed indoors on March 22, 2020 in an unprecedented and overwhelming response to Prime Minister Narendra Modi's appeal for the nationwide curfew. People used to come out briefly at 5 pm to show their gratitude to healthcare and other essential service providers with sounds of bells, conches and claps.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

Second dry run of COVID-19 inoculation conducted

Second dry run of COVID-19 inoculation conducted

Rediff.com8 Jan 2021

The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

USFDA denies Covaxin emergency use nod, to take 'full approval' route

USFDA denies Covaxin emergency use nod, to take 'full approval' route

Rediff.com11 Jun 2021

In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

Sensex ends below 27K-mark on Fed worries, Middle East tension

Sensex ends below 27K-mark on Fed worries, Middle East tension

Rediff.com11 Sep 2014

On the gaining side, Hero Moto, SBI, HDFC, HUL and L&T have gained between 1-1.4 per cent.

9 Changes To Improve Your Sexual Health

9 Changes To Improve Your Sexual Health

Rediff.com10 Feb 2023

Don't be afraid to prioritise your sexual well-being and nurture a positive relationship with sex, suggests Maitri Trivedi.

Focus on double vaccination first: Experts amid calls for booster

Focus on double vaccination first: Experts amid calls for booster

Rediff.com4 Dec 2021

'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

'Don't deserve this': Bharat Biotech hits outs at critics

'Don't deserve this': Bharat Biotech hits outs at critics

Rediff.com4 Jan 2021

He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".

Surprise checks on drug trials soon

Surprise checks on drug trials soon

Rediff.com13 Sep 2008

Hospitals and medical research organisations that conduct clinical trials on humans may soon face surprise inspections from the regulatory authorities. The hospitals, the sponsor pharma companies and the institutional ethics committees that oversee these trials will all come under the regulator's scanner.

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

Rediff.com17 Sep 2021

India's top vaccinologist Gagandeep Kang stressed the need to develop better vaccines that can deal with new variants, and strengthening of the regulatory mechanisms.

'Tharanga tested positive for drugs during WC'

'Tharanga tested positive for drugs during WC'

Rediff.com29 May 2011

Sri Lanka opening batsman Upul Tharanga tested positive for an banned substance at this year's World Cup, an International Cricket Council (ICC) source told Reuters on Sunday.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

Masks, hand sanitiser declared 'essential commodities'

Masks, hand sanitiser declared 'essential commodities'

Rediff.com14 Mar 2020

These items will remain under essential commodities segment till June-end, a move aimed at ensuring availability at reasonable prices and cracking down on hoarders/black marketeers.

Winter session begins today, farm law repeal among 26 bills on agenda

Winter session begins today, farm law repeal among 26 bills on agenda

Rediff.com29 Nov 2021

The government's agenda also includes the Cryptocurrency and Regulation of Official Digital Currency Bill, 2021.

UK's new antibody treatment against Covid may work against Omicron

UK's new antibody treatment against Covid may work against Omicron

Rediff.com2 Dec 2021

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

19 deaths not causally related to vaccination reported till Feb 4: Govt

19 deaths not causally related to vaccination reported till Feb 4: Govt

Rediff.com9 Feb 2021

Choubey said till February 4 total 81 AEFIs, which is 0.096 per cent of the total beneficiaries who have been administered Covaxin, have been reported.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.